JP2012131811A5 - - Google Patents

Download PDF

Info

Publication number
JP2012131811A5
JP2012131811A5 JP2012034259A JP2012034259A JP2012131811A5 JP 2012131811 A5 JP2012131811 A5 JP 2012131811A5 JP 2012034259 A JP2012034259 A JP 2012034259A JP 2012034259 A JP2012034259 A JP 2012034259A JP 2012131811 A5 JP2012131811 A5 JP 2012131811A5
Authority
JP
Japan
Prior art keywords
vomiting
emesis
nausea
palonosetron
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012034259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012131811A (ja
JP5893950B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012131811A publication Critical patent/JP2012131811A/ja
Publication of JP2012131811A5 publication Critical patent/JP2012131811A5/ja
Application granted granted Critical
Publication of JP5893950B2 publication Critical patent/JP5893950B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2012034259A 2002-11-15 2012-02-20 化学療法誘導嘔吐を治療するためのパロノセトロン Expired - Lifetime JP5893950B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42682902P 2002-11-15 2002-11-15
US60/426,829 2002-11-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004553037A Division JP5690461B2 (ja) 2002-11-15 2003-11-06 化学療法誘導嘔吐を治療するためのパロノセトロン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015086840A Division JP2015143266A (ja) 2002-11-15 2015-04-21 化学療法誘導嘔吐を治療するためのパロノセトロン

Publications (3)

Publication Number Publication Date
JP2012131811A JP2012131811A (ja) 2012-07-12
JP2012131811A5 true JP2012131811A5 (https=) 2014-04-17
JP5893950B2 JP5893950B2 (ja) 2016-03-23

Family

ID=32326433

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2004553037A Expired - Lifetime JP5690461B2 (ja) 2002-11-15 2003-11-06 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2012034259A Expired - Lifetime JP5893950B2 (ja) 2002-11-15 2012-02-20 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2015086840A Pending JP2015143266A (ja) 2002-11-15 2015-04-21 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2016162972A Expired - Lifetime JP6342960B2 (ja) 2002-11-15 2016-08-23 化学療法誘導嘔吐を治療するためのパロノセトロン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004553037A Expired - Lifetime JP5690461B2 (ja) 2002-11-15 2003-11-06 化学療法誘導嘔吐を治療するためのパロノセトロン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015086840A Pending JP2015143266A (ja) 2002-11-15 2015-04-21 化学療法誘導嘔吐を治療するためのパロノセトロン
JP2016162972A Expired - Lifetime JP6342960B2 (ja) 2002-11-15 2016-08-23 化学療法誘導嘔吐を治療するためのパロノセトロン

Country Status (6)

Country Link
US (2) US20060079545A1 (https=)
JP (4) JP5690461B2 (https=)
AU (1) AU2003302072A1 (https=)
CA (1) CA2505990C (https=)
DE (1) DE10393729T5 (https=)
WO (1) WO2004045615A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232832B2 (en) * 2002-11-05 2007-06-19 Smithkline Beecham Corporation Antibacterial agents
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
MY143789A (en) * 2003-02-18 2011-07-15 Helsinn Healthcare Sa Use of palonosetron treating post- operative nausea and vomiting
KR101441459B1 (ko) * 2006-10-24 2014-09-18 헬신 헬쓰케어 에스.에이. 안정성 및 생체이용률이 개선된 염산 팔로노세트론을 포함하는 연질 캡슐
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
ES2563061T3 (es) * 2008-04-28 2016-03-10 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
EP2286814B1 (en) 2008-05-15 2013-10-16 Hisamitsu Pharmaceutical Co., Inc. Transdermal preparation containing palonosetron
US20100048607A1 (en) * 2008-08-25 2010-02-25 Chandrashekhar Kocherlakota Formulations comprising palonosetron
EP2364138A2 (en) * 2008-12-08 2011-09-14 Teva Pharmaceutical Industries Ltd. Palonosetron formulation
CN102781939A (zh) 2009-11-13 2012-11-14 赫尔辛医疗股份公司 帕洛诺司琼代谢物
ES2623503T3 (es) 2009-11-18 2017-07-11 Helsinn Healthcare Sa Composiciones para tratar náuseas y vómitos mediados centralmente
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
WO2016118540A1 (en) * 2015-01-20 2016-07-28 Xoc Pharmaceuticals, Inc. Treating and/or preventing emesis and/or nausea including acute and/or delayed nausea and/or emesis
JP6642377B2 (ja) * 2016-10-25 2020-02-05 ニプロ株式会社 液体製剤、及び、パロノセトロンの安定性を向上する方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US807381A (en) * 1905-01-10 1905-12-12 Auto Stopper Company Means for securing stoppers for vessels in their caps.
US1796729A (en) * 1930-04-18 1931-03-17 Aluminum Co Of America Closure
US2069075A (en) * 1934-04-20 1937-01-26 United Dairies London Ltd Bottle or like container
US2113176A (en) * 1936-03-26 1938-04-05 Guardian Safety Seal Company Sealed receptacle
US3314564A (en) * 1965-05-06 1967-04-18 West Co Container closure
US3601273A (en) * 1969-01-31 1971-08-24 Aluminum Co Of America Pilferproof closure with vertical weakening lines
DE2315962A1 (de) * 1972-04-05 1973-10-18 Metal Closures Ltd Verschlusskappenrohling fuer flaschen od. dgl.
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
US4937247A (en) * 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
DE3650772T2 (de) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivate von Indazole-3-carboxamide und -3-carboxylsäure
US5240954A (en) * 1985-06-25 1993-08-31 Glaxo Group Limited Medicaments
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
US4906755A (en) * 1986-11-03 1990-03-06 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
US5011846A (en) * 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
PL166267B1 (pl) * 1989-11-28 1995-04-28 Syntex Inc Sposób wytwarzania nowych zwiazków trójpierscieniowych PL PL PL PL
GB2277749B (en) * 1993-05-08 1996-12-04 Ciba Geigy Ag Fluorescent whitening of paper
GB9423511D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US6294548B1 (en) * 1998-05-04 2001-09-25 Hoffmann-La Roche Inc. Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
US20030127420A1 (en) * 2002-01-09 2003-07-10 Klaus Schumacher Dual bottle closure
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
MY143789A (en) * 2003-02-18 2011-07-15 Helsinn Healthcare Sa Use of palonosetron treating post- operative nausea and vomiting

Similar Documents

Publication Publication Date Title
JP2012131811A5 (https=)
MX2020003381A (es) Composicion para la prevencion o el tratamiento de enfermedades relacionadas con el factor de necrosis tumoral (tnf), que contiene un nuevo derivado como ingrediente activo, y metodo para inhibir la actividad del factor de necrosis tumoral (tnf) mediante el uso de la misma.
HK1198869A1 (en) Combination treatments for hepatitis c
SA522432668B1 (ar) طرق لعلاج سرطان الرئة للخلايا الصغيرة بصيغ من لوربينيكتيدين
AR095338A1 (es) Método de tratamiento no tóxico para la abstinencia de drogas
AR070026A1 (es) Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
RU2017134443A (ru) Способ лечения с применением традипитанта
MX2022005596A (es) Regimen de dosificacion para agentes anti-dll3.
JP2019511496A5 (https=)
MX2023000187A (es) Dosificacion de vibegron para el tratamiento de vejiga sobreactiva.
JP2019530706A5 (https=)
MX2022015629A (es) Uso de vibegron para tratar vejiga sobreactiva.
MX389336B (es) Formulacion farmaceutica.
JP2018506533A5 (https=)
FI3359572T3 (fi) Menetelmä multippeliskleroosin hoitamiseksi
AR088453A1 (es) Regimen de dosificacion del agonista o modulador del receptor de s1p
JP2014502608A5 (https=)
TN2016000179A1 (en) Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor.
IL275091B2 (en) Methods for treating gaucher disease
RU2013126798A (ru) Комбинированная терапия дексаметазоном
MX393290B (es) Composicion para el tratamiento de la osteoartritis
AR114012A1 (es) Método para proporcionar terapia de celiprolol a un paciente
AR102903A1 (es) Inhalador de polvo seco
MX2022006535A (es) Métodos para tratar síntomas de comportamiento y psicológicos en pacientes con demencia.
BR112018002433A2 (pt) composição farmacêutica para tratamento da enxaqueca